Mar 5, 2026 07:00AM
Jan 8, 2026 09:05AM
Jan 8, 2026 09:05AM
Jan 5, 2026 07:01AM
Jan 5, 2026 07:00AM
Dec 22, 2025 07:06AM
Dec 12, 2025 10:47AM Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance
Nov 4, 2025 09:00AM
Oct 23, 2025 07:00AM
Oct 23, 2025 07:00AM
Oct 6, 2025 07:00AM
Aug 5, 2025 07:00AM
Jun 27, 2025 07:03AM
Jun 27, 2025 07:00AM Tango Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of TNG462 plus Revolution Medicines’ Daraxonrasib or Zoldonrasib in Patients with RAS-Mutant MTAP-deleted Pancreatic or Lung Canc
May 21, 2025 07:01AM
May 21, 2025 07:00AM
May 12, 2025 07:00AM
Apr 9, 2025 05:00AM
Feb 27, 2025 07:00AM
Jan 2, 2025 12:51PM
Nov 6, 2024 07:02AM Tango Therapeutics, Inc (TNGX) Reports Positive TNG462 Clinical Data, Provides Update on PRMT5 Development Program
Nov 6, 2024 07:00AM
Mar 18, 2024 07:00AM
Jan 3, 2024 07:00AM
Nov 8, 2023 07:00AM
Sep 6, 2023 07:06AM
Sep 6, 2023 07:00AM
Aug 28, 2023 07:00AM Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer
Aug 7, 2023 07:00AM
Jul 24, 2023 07:00AM
Jul 10, 2023 07:00AM
May 9, 2023 07:00AM
Apr 3, 2023 07:06AM
Apr 3, 2023 07:00AM
Mar 27, 2023 07:00AM Tango Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Highlights
Jan 25, 2023 07:00AM
Jan 25, 2023 07:00AM
Aug 10, 2022 07:00AM
May 11, 2022 07:00AM
Mar 28, 2022 07:00AM
Jan 24, 2022 07:01AM
Jan 24, 2022 07:00AM Tango Therapeutics Announces Clearance of TNG908 IND by FDA and Recent Pipeline Progress Updates

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All